医学
三阴性乳腺癌
内科学
多西紫杉醇
乳腺癌
肿瘤科
临床研究阶段
化疗
紫杉烷
癌症
作者
Andrew W. Chung,Kartik Anand,Ann C. Anselme,Alfred A. Chan,Nakul Gupta,Luz A. Venta,Mary R. Schwartz,Wei Qian,Yitian Xu,Licheng Zhang,John G. Kuhn,Tejal Patel,Angel Rodriguez,Anna Belcheva,Jorge Darcourt,Joe Ensor,Eric Bernicker,Ping‐Ying Pan,Shu‐Hsia Chen,Delphine J. Lee,Polly Niravath,Jenny C. Chang
出处
期刊:Science Translational Medicine
[American Association for the Advancement of Science (AAAS)]
日期:2021-12-15
卷期号:13 (624)
被引量:62
标识
DOI:10.1126/scitranslmed.abj5070
摘要
A phase 1/2 clinical trial in patients with chemoresistant triple-negative breast cancer targets the inducible nitric oxide signaling pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI